US Stock MarketDetailed Quotes

Pfizer (PFE)

Watchlist
  • 27.310
  • -0.210-0.76%
Close Apr 21 16:00 ET
  • 27.364
  • +0.054+0.20%
Pre 05:12 ET
155.35BMarket Cap20.08P/E (TTM)

About Pfizer Company

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Company Profile

SymbolPFE
Company NamePfizer
Listing DateJan 17, 1944
ISINUS7170811035
Founded1849
CEODr. Albert Bourla, D.V.M.,PhD
MarketNYSE
Employees75000
Fiscal Year Ends12-31
Address66 Hudson Boulevard East
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10001-2192
Phone1-212-733-2323
Websitehttp://www.pfizer.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Albert Bourla, D.V.M.,PhD
  • Chairman of the Board and Chief Executive Officer
  • 27.59M
  • Payal Sahni
  • Chief People Experience Officer and Executive Vice President
  • --
  • Lidia L. Fonseca
  • Executive Vice President, Chief Digital and Technology Officer
  • --
  • Michael McDermott
  • Executive Vice President, Chief Global Supply and Quality Officer
  • --
  • Douglas M. Lankler
  • Chief Legal Officer and Executive Vice President
  • 9.11M
  • David M. Denton
  • Chief Financial Officer and Executive Vice President
  • 9.67M
  • Alexandre de Germay
  • Chief International Commercial Officer and Executive Vice President
  • --
  • Aamir Malik
  • Chief U.S. Commercial Officer and Executive Vice President
  • 9.43M
  • Dr. Chris Boshoff, M.D.,PhD
  • Chief Scientific Officer and President, Research and Development
  • 10.01M
  • Dr. Andrew Baum, M.D.
  • Executive Vice President, Chief Strategy and Innovation Officer
  • --
  • Jennifer B. Damico
  • Principal Accounting Officer, Senior Vice President and Controller
  • --
  • Margaret M. Madden
  • Senior Vice President, Corporate Secretary and Chief Governance Counsel
  • --
  • Suzanne Nora Johnson
  • Independent Director
  • 410.00K
  • Shantanu Narayen
  • Lead Independent Director
  • 410.00K
  • Ronald E. Blaylock
  • Independent Director
  • 360.00K
  • Mortimer J. Buckley
  • Independent Director
  • 360.00K
  • Joseph J. Echevarria
  • Independent Director
  • 400.37K
  • James Robert Quincey
  • Independent Director
  • 380.00K
  • James C. Smith
  • Independent Director
  • 390.00K
  • Cyrus Taraporevala
  • Independent Director
  • 380.00K
  • Dr. Susan J. Hockfield, PhD
  • Independent Director
  • 372.00K
  • Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H.
  • Independent Director
  • 380.52K
  • Dr. Scott Gottlieb,M.D.
  • Independent Director
  • 393.50K
  • Dr. Dan R. Littman, M.D.,PhD
  • Independent Director
  • 380.00K
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.00%
Sample Name
Sample Code
 +12.85%
Sample Name
Sample Code
 +9.97%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+9.57%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+5.29%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +34.94%
Sample Name
Sample Code
 +28.57%
Sample Name
Sample Code
 +11.29%
4
ASE Technology
ASX
+10.16%
5
Pony AI
PONY
+7.63%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 21 EST, Iran's Tasnim News Agency reported that Iran had ultimately decided not to attend the talks scheduled for Wednesday, April Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -